ArticleTherapeutic advances in musculoskeletal disease2021

Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a

Ahmad Y Abuhelwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.